6505NCM162796: SARGRAMOSTIM FOR INJECTION.
The SARGRAMOSTIM FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: FREEZE-DRIED POWDER, administration: SUBCUTANEOUS AND INTRAVENOUS INFUSION, features_provided: STERILE, primary_container_type: VIAL, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING, primary_container_content_quantity: 250.00 MICROGRAMS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-654-2233, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | FREEZE-DRIED POWDER |
| administration | SUBCUTANEOUS AND INTRAVENOUS INFUSION |
| features_provided | STERILE |
| primary_container_type | VIAL |
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| primary_container_content_quantity | 250.00 MICROGRAMS |
| active_medicament_medicinal_strength | 250.00 MICROGRAMS SARGRAMOSTIM ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | LEUKINE (SARGRAMOSTIM) INJ, 250 MCG PER VIAL, 5'S |
| NSN | 6505-01-654-2233 |
| ADMINISTRATION | SUBCUTANEOUS AND INTRAVENOUS INFUSION |
| PRIMARY CONTAINER CONTENT QUANTITY | 250.00 MICROGRAMS |
| USUAL DOSE | 250 MCG/M2/DAY FOR 14 DAYS AS A 2-HOUR IV INFUSION; THE DOSE CAN BE REPEEATED AFTER 7 DAYS OFF THERAPY IF ENGRAFTMENT HAS NOT OCCURRED; IF ENGRAFTMENT STILL HAS NOT OCCURRED, A THIRD COURSE OF 500 MCG/M2/DAY FOR 14 DAYS MAY BE TRIED AFTER ANOTHER 7 DAYS OFF THERAPY |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | FREEZE-DRIED POWDER |
| SPECIAL FEATURES | SARGRAMOSTIM 250 MCG PER VIAL; CONTAINS 250 MCG OF PRESERVATIVE-FREE LYOPHILIZED SARGRAMOSTIM; PACKAGE OF 5 VIALS; SHOULD BE REFRIGIRATED BETWEEN 2-8DEG (36-46 F); DO NOT FREEZE OR SHAKE; FOR SUBCUTANEOUS INJECTION OR IV INFUSION |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LEUKINE (SARGRAMOSTIM) INJ, 250 MCG PER VIAL, 5'S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.00 MICROGRAMS SARGRAMOSTIM ACTIVE INGREDIENT |